Despite all IDH-mutant gliomas seeming to originate from a shared progenitor [7,28], oligodendrogliomas and astrocytomas differ according to morphological aspects, genetic mutations, and TME composition, with subsequent differences in tumor behavior and clinical outcomes. Here, IDH2 is linked to astrocytoma (excluding glioblastoma).